NEOGEN RAISED RS 296 CR FUNDS FROM QIB

• QIP was oversubscribed 6.5x; proceeds used for debt repayment and growth. • Q2FY27 revenue up 42% at ₹296 Cr; Ebitda up 51% at ₹45 Cr; PAT up 144% at ₹8 Cr. • Dahej insurance claim accepted at ₹152 Cr; total on-account claim received/receivable ₹316 Cr; CRISIL outlook revised to CRISIL A-/Stable from Negative. • Impact: ₹600 Cr QIP supports debt repayment and growth; oversubscription signals investor demand.

Neogen Chemicals Ltd

Open attachment

← Back to feed